NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
155 hedge funds and large institutions have $921M invested in NEVRO CORP. in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 64 increasing their positions, 51 reducing their positions, and 24 closing their positions.
27% more call options, than puts
Call options by funds: $6.55M | Put options by funds: $5.15M
25% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 51
4% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 24
2% less funds holding
Funds holding: 158 → 155 (-3)
28% less capital invested
Capital invested by funds: $1.28B → $921M (-$360M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$68M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$15.9M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$14M |
| 4 |
D.E. Shaw & Co
New York
|
+$7.75M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$53.7M |
| 2 |
Millennium Management
New York
|
-$16.4M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$13M |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$6.81M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$5.66M |
NVRO Hedge Fund Activity: Q2 2023 in Review
155 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2023, worth a combined $921M — down 28% from $1.28B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of NVRO and 23 opened new positions — a net loss of 1 holder — while 51 trimmed existing stakes and 64 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $68M. The largest seller was Fidelity Investments, cutting an estimated $53.7M.
- 155 institutional investors held NEVRO CORP. (NVRO) as of Q2 2023, down from 158 in Q1 2023.
- Funds reported $921M of NEVRO CORP. stock for Q2 2023, down 28% quarter-over-quarter.
- 23 funds opened new NEVRO CORP. positions in Q2 2023 and 24 closed out, a net change of -1 holder.
- The largest NEVRO CORP. buyer in Q2 2023 was Armistice Capital, an estimated $68M added.
- The largest NEVRO CORP. seller in Q2 2023 was Fidelity Investments, an estimated $53.7M sold.
Based on aggregated 13F filings for Q2 2023.